Not available
Quote | Trinity Biotech plc (NASDAQ:TRIB)
Last: | $2.04 |
---|---|
Change Percent: | 4.21% |
Open: | $2.05 |
Close: | $2.04 |
High: | $2.1769 |
Low: | $2.04 |
Volume: | 16,604 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Trinity Biotech plc (NASDAQ:TRIB)
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
2024-06-21 16:39:51 ET More on Trinity Biotech Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript Historical earnings data for Trinity Biotech Financial information for Trinity Biotech ...
Message Board Posts | Trinity Biotech plc (NASDAQ:TRIB)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $TRIB News Article - Trinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Ken | whytestocks | investorshangout | 03/22/2023 7:45:46 PM |
whytestocks: $TRIB News Article - Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Fin | whytestocks | investorshangout | 12/09/2022 1:10:46 PM |
Close at .98 would be a nice double | StockLogistics | investorshub | 09/06/2022 7:01:09 AM |
whytestocks: $TRIB News Article - Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial | whytestocks | investorshangout | 04/11/2022 2:10:50 PM |
Today. | stocks2watch | investorshub | 04/11/2022 1:09:48 PM |
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the launch of its continuous glucose monitoring (“CGM”...